Bruker Corp. (BRKR)
NASDAQ
Closed
Oct 8, 2026
Day's Range
56.2952 wk Range
32.37Overview - BRKR - Bruker Corp.
Key Statistics
Valuation
Enterprise Value
11.35B
P/E (Trailing)
‪74.88‬
P/E (Forward)
‪26.45‬
PEG Ratio
‪-0.08‬
Price / Sales (TTM)
‪2.75‬
Price / Book
‪4.04‬
EV / EBITDA
‪20.99‬
Profitability
Gross Margin
‪49.61%‬
Profit Margin
‪-2.03%‬
Operating Margin
‪9.87%‬
Return on Assets
‪3.13%‬
Return on Equity
‪-2.99%‬
Ownership
Shares Outstanding
152.35M
Float
103.68M
Short % of Shares Outstanding
‪15.80%‬
Held by Insiders
‪26.96%‬
Held by Institutions
‪95.23%‬
Price stats
Beta
‪1.26‬
50-Day Avg
‪58.88‬
200-Day Avg
‪49.21‬
Dividends
Payout Ratio
‪38.45%‬
Frequency
Quarterly
Analyst Consensus
13 analysts
Average price target
‪$ 58.75‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BRKR - Bruker Corp.
Peers - BRKR - Bruker Corp.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - BRKR - Bruker Corp.
About
Bruker Corp. is a scientific instruments and analytical solutions company that provides technologies for life science, materials research, and diagnostic applications. The company develops, manufactures, and distributes high-performance tools used to study matter at microscopic, molecular, and cellular levels,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
